RAS

Events

Partner Content

For decades, RAS has existed as an elusive therapeutic target, and drugging this high-value oncogene was deemed impossible.

News

Study suggests routine genomic testing could correct well-established disparities in breast cancer survival rates between white and black women.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.